The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clarithromycin-Resistant Genotypes and Eradication of Helicobacter pylori
Abstract
BACKGROUND: Three point mutations (A2143G, A2142G, and A2142C) have been involved in Helicobacter pylori clarithromycin resistance. OBJECTIVE: To compare the eradication rates among the different point mutations and the efficacy of triple therapy and a sequential regimen according to genotypic resistance. DESIGN: Post hoc subgroup study from a multicenter, randomized trial. SETTING: Two hospitals in central and southern Italy between January and December 2001. PATIENTS: 156 patients with H. pylori infection. MEASUREMENTS: Real-time polymerase chain reaction for assessing clarithromycin resistance; histology, rapid urease test, and 13C-urea breath test at entry and after 4 to 6 weeks. INTERVENTION: 7-day triple therapy (20 mg of rabeprazole, 500 mg of clarithromycin, and 1 g of amoxicillin) in 75 patients or a 10-day sequential regimen (20 mg of rabeprazole plus 1 g of amoxicillin for 5 days and 20 mg of rabeprazole, 500 mg of clarithromycin, and 500 mg of tinidazole for the remaining 5 days) in 81 patients. All drugs were given twice daily. RESULTS: Helicobacter pylori infection was eradicated in 11 of 23 patients (48%) with the A2143G mutation and in 14 of 15 patients (93%) with either A2142G or A2142C strains (difference, 45 percentage points [95% CI, 15 to 65 percentage points]; P = 0.004). The sequential regimen achieved a higher cure rate than triple therapy in A2143G mutate strains (difference, 49 percentage points [CI, 8 to 72 percentage points]; P = 0.024). LIMITATIONS: The post hoc substudy design may require further confirmation. Other limitations are the accessibility to the tool and the cost of investigations (70 euros per patient). CONCLUSIONS: The A2143G mutation seemed to be associated with a very low eradication rate. The sequential regimen achieved a higher cure rate than standard therapy even in patients with these strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Saeed, Z. A., & Malaty, H. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-705 · Cited by 909
Cited by
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01393.x · Cited by 1,406
Beyond the stomach: An updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment
Testerman, T. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12781 · Cited by 336
Jafri, N. S., Hornung, C. A., & Howden, C. W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00226 · Cited by 296
Gatta, L., Vakil, N., Leandro, G., Mario, F. D., & Vaira, D. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.555 · Cited by 274
Liou, J.-M., Chen, C.-C., Chen, M.-J., Chen, C.-C., Chang, C.-Y., Fang, Y.-J., Lee, J., Hsu, S.-J., Luo, J.-C., Chang, W.-H., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61579-7 · Cited by 269
Metadata
- Authors
- De Francesco, V., Margiotta, M., Zullo, A., Hassan, C., Troiani, L., Burattini, O., Stella, F., Di Leo, A., Russo, F., Marangi, S., Monno, R., Stoppino, V., Morini, S., Panella, C., & Ierardi, E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-01-17
- Volume
- 144
- Issue
- 2
- Pages
- 94-100
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2132339174
- Cited by
- 199
- References
- 1
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clarithromycin-Resistant Genotypes and Eradication of Helicobacter pylori. https://app.cochat.ai/papers/10.7326/0003-4819-144-2-200601170-00006
- The paper
- De Francesco, V., Margiotta, M., Zullo, A., Hassan, C., Troiani, L., Burattini, O., Stella, F., Di Leo, A., Russo, F., Marangi, S., Monno, R., Stoppino, V., Morini, S., Panella, C., & Ierardi, E. (2006). Clarithromycin-Resistant Genotypes and Eradication of Helicobacter pylori. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-144-2-200601170-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.